Researchers at the University of Bath and the University of Sheffield have released the first real-world modeling of a "polluter pays" tobacco levy—a scheme that could reshape how the UK tackles smoking-related harm. The study, published in Social Science & Medicine, shows that a maximum wholesale price cap on tobacco products could raise between £1 billion and £4.9 billion over five years, depending on implementation speed and price level, while simultaneously preventing up to 10,000 hospital admissions over two decades.
The proposal targets a fundamental lever of tobacco industry marketing: price. Under the scheme, the government would set a ceiling on what manufacturers can charge wholesalers for cigarettes and vaping products, then adjust tax rates upward to keep shop prices steady. This prevents the industry from using discounts and promotions to attract customers—a tactic especially effective in drawing people from lower-income households into nicotine dependence. The revenue generated comes directly from industry profits rather than from smokers' pockets or small retailers.
The research tracked 250,000 individuals aged 18 to 89 across England, testing six different scenarios with varying price caps and implementation timelines. The most aggressive scenario—an immediate hard cap—painted a striking picture: by 2029, the levy would raise £4.9 billion in government revenue. By 2044, England would see 1,636 fewer deaths, 43,987 fewer years of life lost, and 10,073 fewer hospital admissions directly attributable to reduced smoking rates. Remarkably, these gains came without increasing overall consumer spending. As Dr. Duncan Gillespie, the study's lead author from the University of Sheffield, noted in the research: "Meaningful improvements in public health can be achieved without placing an additional financial burden on consumers."
The logic underpinning the levy reflects a practical reality: cigarettes currently range from about £13 to £20 for a pack of 20, despite being equally harmful. A price cap that standardizes these products at a higher floor removes what the tobacco industry uses as a gateway—affordable entry pricing for the most vulnerable. The poorest 20% of the population would see the greatest health benefit, according to the modeling, as they're most price-sensitive and most affected by smoking-related disease.
This research transforms what has long remained theoretical. Health organizations including ASH (UK), Cancer Research UK, and STOP have championed the "polluter pays" concept for years, and it has appeared in political manifestos. The UK government's recent passage of the Tobacco and Vapes Act demonstrated commitment to reducing smoking harm. Dr. Rob Branston, co-director of the University of Bath Tobacco Control Research Group, framed the lever opportunity clearly: "Tobacco prices vary considerably...if you introduce a polluter pays levy and then charge them all at £20, not only will fewer people be able to afford to smoke, but you'd also likely gain more tax revenue for the government."
Public support for making tobacco companies bear the cost of their products' harm is overwhelming, according to advocates. The modeling suggests that opportunity is no longer speculative—it's quantified and ready for policy consideration. For a government seeking both public health gains and revenue solutions, the data makes a compelling case: shift the burden from taxpayers and smokers onto an industry that, as Dr. Branston notes, "kills more than half of its long-term users."